4 Current news of Stratophase
rssPortable optical microchip technology accurately detects Foot and Mouth Disease in laboratory tests
06-21-2011
Stratophas has announced the successful completion of the Portable Direct Immunoassay Diagnosis Devices for Animals and Humans (PDIDDAH) project. Using Stratophase’s proprietary optical microchip technology, the goal of the proof-of-principle study was to assess the feasibility of using a ...
07-16-2010
Stratophase has doubled its sensor chip manufacturing capability and moved to a larger site. Three times larger than the old building, Stratophase’s new facility has been fitted with offices, meeting rooms and high tech laboratory space, and has the capacity to expand further with minimal ...
03-03-2010
Stratophase announced that, as part of a consortium of companies, it is developing a cost-effective, multi-parametric, multi-point, in-line sensor system for high-value liquid production processes. Utilising Stratophase's advanced SpectroSens optical microchip technology, this £1.2m project ...
New funding supports roll out of Early Access Programme for SpectroSens real-time monitoring technology
02-02-2010
Stratophase has started the new year by securing £2.5m follow-on funding from existing investor East Hill Management. Commenting on the funding, Dr Richard Williams, CEO of Stratophase said, “These are exciting times for Stratophase. We are initiating a SpectroSens Early Access Programme ...
